Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cutis verticis gyrata (CVG) is a progressive cutaneous disorder predominantly affecting males and characterized by hypertrophy and thickening of the skin of the scalp forming convoluted furrows with deep, tender, and cerebriform cutaneous folds. Hair is usually normal in the furrows and sparse on the folds. CG can be isolated (essential CVG) or associated with other abnormalities such as intellectual deficit, epilepsy, cataract, blindness, and deafness (non essential CVG).
Biomarker and diagnostic research for primary cutis verticis gyrata has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for primary cutis verticis gyrata.
19 publications have been identified in PubMed for primary cutis verticis gyrata. Research spans Case Report / Case Series (68%), Review / Meta-Analysis (16%), and Other (5%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 13 | 68% |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 7:14 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
3 |
16% |
Other research | 1 | 5% |
Testing and diagnosis research | 1 | 5% |
New treatment approaches | 1 | 5% |
Shareef S (2026). [PMID: 30969634](https://pubmed.ncbi.nlm.nih.gov/30969634/). *Unknown Journal*. [Review / Meta-Analysis]
Staunton MK (2026). [PMID: 42011393](https://pubmed.ncbi.nlm.nih.gov/42011393/). *JAAD Case Rep*. [Case Report / Case Series]
Stoian M (2026). [PMID: 41682637](https://pubmed.ncbi.nlm.nih.gov/41682637/). *Journal of clinical medicine*. [Case Report / Case Series]
Demir BM (2026). [PMID: 41742351](https://pubmed.ncbi.nlm.nih.gov/41742351/). *International journal of dermatology*. [Case Report / Case Series]
Baksanskaite J (2025). [PMID: 39911976](https://pubmed.ncbi.nlm.nih.gov/39911976/). *Skin appendage disorders*. [Gene Therapy / Novel Therapeutics]
Hoenig LJ (2025). [PMID: 40220803](https://pubmed.ncbi.nlm.nih.gov/40220803/). *Clin Dermatol*. [Other]
Foriers B (2025). [PMID: 40620552](https://pubmed.ncbi.nlm.nih.gov/40620552/). *Journal of the Belgian Society of Radiology*. [Diagnostic / Biomarker]
Hirpara M (2025). [PMID: 40787049](https://pubmed.ncbi.nlm.nih.gov/40787049/). *JAAD case reports*. [Case Report / Case Series]
Arcanjo AM (2025). [PMID: 40144454](https://pubmed.ncbi.nlm.nih.gov/40144454/). *JBMR plus*. [Case Report / Case Series]
Sutedja EK (2025). [PMID: 40486216](https://pubmed.ncbi.nlm.nih.gov/40486216/). *Clinical, cosmetic and investigational dermatology*. [Case Report / Case Series]